Stay updated on Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New study sites in Chiba, Sapporo, and Ishikawa (with local institution IDs) were added and several centers were removed. Revision 3.3.2 and updated milestone dates (e.g., 2025-11-21, 2026-02-27, 2031-02-27) accompany these changes.
    Difference
    0.7%
    Check dated 2025-11-26T13:49:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the notice about government funding and NIH operating status from the page; this does not affect the study details, eligibility criteria, or results information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-19T08:25:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added two Tainan locations (Tainan, Taiwan, 736 and Tainan, TNN, Taiwan, 704) and removed two Tainan City entries (Tainan City, Taiwan, 736; Tainan City, Taiwan, 704).
    Difference
    0.0%
    Check dated 2025-11-12T00:01:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page changes appear limited to cosmetic layout updates and do not modify core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:09:56.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Release v3.2.0 is introduced with a government-funding notice and updated operating status information; prior v3.1.0 is removed.
    Difference
    3%
    Check dated 2025-10-06T16:03:37.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.
    Difference
    0.3%
    Check dated 2025-09-29T09:54:57.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.